INO logo

Inovio Pharmaceuticals (INO) Company Overview

Profile

Full Name:

Inovio Pharmaceuticals, Inc.

Sector:

Healthcare

Industry:

Biotechnology

Country:

United States

IPO:

December 8, 1998

Indexes:

Not included

Description:

Inovio Pharmaceuticals (INO) is a biotechnology company focused on developing DNA-based therapies and vaccines. They aim to treat cancer and infectious diseases using innovative technology that helps the body produce its own immune response. Their research includes clinical trials to test the effectiveness of these treatments.

Key Details

Price

$1.97

Annual Revenue

$832.00 K(-91.89% YoY)

Annual EPS

-$6.09(+56.72% YoY)

Annual ROE

-79.55%

Beta

1.46

Events Calendar

Earnings

Next earnings date:

Mar 13, 2025

Recent quarterly earnings:

Nov 14, 2024

Recent annual earnings:

Mar 6, 2024
Dividend

Next ex-dividend date:

N/A

Recent ex-dividend date:

N/A
Splits

Next split:

N/A

Recent split:

Jan 25, 2024

Analyst ratings

Recent major analysts updates

Jan 13, 25 HC Wainwright & Co.
Neutral
Jan 10, 25 JMP Securities
Market Outperform
Nov 18, 24 Oppenheimer
Outperform
Nov 18, 24 HC Wainwright & Co.
Neutral
Nov 15, 24 RBC Capital
Sector Perform
Aug 12, 24 Oppenheimer
Outperform
Aug 9, 24 RBC Capital
Sector Perform
Jul 15, 24 HC Wainwright & Co.
Neutral
May 14, 24 Stephens & Co.
Overweight
Mar 8, 24 Oppenheimer
Outperform

Market Data

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Price

Market cap

Technical

Dividend

Profitability

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Revenue

Profit

EPS

ROA & ROE

EBIT & EBITDA

Valuation

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

PE Ratio

PB Ratio

PS Ratio

Enterprise value

EV/EBITDA

Financial Health

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Liquidity

Leverage

Risk & Stability

Balance Sheet

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Assets

Equity

Liabilities

Debt

Expenses

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Cash Flow

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Cashflow Activities

Free CashFlow

CAPEX

Institutional Ownership

FAQ

  • What is the ticker symbol for Inovio Pharmaceuticals?
  • Does Inovio Pharmaceuticals pay dividends?
  • What sector is Inovio Pharmaceuticals in?
  • What industry is Inovio Pharmaceuticals in?
  • What country is Inovio Pharmaceuticals based in?
  • When did Inovio Pharmaceuticals go public?
  • Is Inovio Pharmaceuticals in the S&P 500?
  • Is Inovio Pharmaceuticals in the NASDAQ 100?
  • Is Inovio Pharmaceuticals in the Dow Jones?
  • When was Inovio Pharmaceuticals's last earnings report?
  • When does Inovio Pharmaceuticals report earnings?
  • Should I buy Inovio Pharmaceuticals stock now?

What is the ticker symbol for Inovio Pharmaceuticals?

The ticker symbol for Inovio Pharmaceuticals is NASDAQ:INO

Does Inovio Pharmaceuticals pay dividends?

No, Inovio Pharmaceuticals does not pay dividends

What sector is Inovio Pharmaceuticals in?

Inovio Pharmaceuticals is in the Healthcare sector

What industry is Inovio Pharmaceuticals in?

Inovio Pharmaceuticals is in the Biotechnology industry

What country is Inovio Pharmaceuticals based in?

Inovio Pharmaceuticals is headquartered in United States

When did Inovio Pharmaceuticals go public?

Inovio Pharmaceuticals's initial public offering (IPO) was on December 8, 1998

Is Inovio Pharmaceuticals in the S&P 500?

No, Inovio Pharmaceuticals is not included in the S&P 500 index

Is Inovio Pharmaceuticals in the NASDAQ 100?

No, Inovio Pharmaceuticals is not included in the NASDAQ 100 index

Is Inovio Pharmaceuticals in the Dow Jones?

No, Inovio Pharmaceuticals is not included in the Dow Jones index

When was Inovio Pharmaceuticals's last earnings report?

Inovio Pharmaceuticals's most recent earnings report was on Nov 14, 2024

When does Inovio Pharmaceuticals report earnings?

The next expected earnings date for Inovio Pharmaceuticals is Mar 13, 2025

Should I buy Inovio Pharmaceuticals stock now?

As of today, analysts generally recommend a 'Buy' rating. However, it's important to do your own research and consider your financial situation before making any investment decisions